Home � Products & Services � Benchmarking Reports � Medical Affairs � Launch Optimization

Building More Effective Medical Affairs Product Launch Teams: Oncology Segment

Download FREE Excerpt

ID: POP-391

Features:

12 Info Graphics

32 Data Graphics

650+ Metrics

18 Narratives

Pages: 56

Published: 2024

Delivery Format: Shipped

License Options:
$6000 - 1 user
$18000 - Up to 5 users
$30000 - Up to 20 users

Buy Now

919-403-0251

Schedule a Meeting

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

Oncology is the most competitive and rapidly advancing therapeutic area in healthcare, where Medical Affairs teams play a pivotal role in ensuring that new treatments reach patients effectively. Medical's involvement is critical in navigating the complexities of cancer treatment and aligning with evolving clinical and regulatory standards.

Best Practices, LLC conducted this research to explore the role of Medical Affairs in successful oncology product launches. This report examines Medical Affairs' evolving responsibilities, cross-functional collaboration, evidence dissemination, resourcing, and the strategic use of digital tools. Our research also identifies the critical success factors and challenges that are unique to oncology, ensuring Medical Affairs teams are positioned to launch effectively and drive impact.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Chemical; Consulting; Communications; Consumer Products; Medical Device; Science

Companies Profiled:
AstraZeneca; Boehringer Ingelheim; Eisai; EMD Serono; Eurofarma; Genentech; GRAIL; Helsinn; Ipsen; Karyopharm Therapeutics; MEDiSTRAVA; Merck KGaA; NexGen Healthcare Communications; Novartis; Pfizer; Pixacore; Sandoz; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies; Thermo Fisher Scientific

Study Snapshot

Best Practices, LLC engaged 27 Medical leaders from 20 leading life sciences companies in this benchmarking research study. Medical Directors and upper management executives represent nearly four-fifths of the leaders who shared data and insights on Medical launch activities in this study.

Key topics covered in this report include:

Medical Leadership Roles and Launch Activity Effectiveness in Oncology
Ensuring Cross-functional Alignment and Collaboration in Oncology Launches
Medical Launch Evolution in Oncology Segment
Oncology Launch Activities Timeline, Performance Tracking, and Resourcing
Critical Success Factors and Major Pitfalls for Medical Affairs During Oncology Launches
Digital Launch Implementation and Impact in Oncology
Launch Tool Deployment for Oncology Products

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Launch Activity Effectiveness: In the oncology segment, Medical Affairs plays a critical role in product launches, particularly in education and support functions. Educational activities are led by 86% of teams, with 78% rating them as effective. Organizational support is led by 53%, with 72% finding it effective. In contrast, Communication and Data Dissemination activities see less leadership (30%), with 67% rating them effective. Research is led by 52%, with 71% finding it effective. These insights highlight the need for stronger leadership in communication efforts to optimize launch success in oncology.

Table of Contents

Sr. No.	Topic	Slide No.
I.	Executive Summary	Pg. 4
II.	Section I: Launch Excellence and Medical’s Role & Activity Effectiveness	Pg. 6-12
III.	Section II: Ensuring Cross-functional Alignment and Collaboration	Pg. 13-15
IV.	Section III: Adopting to Ongoing Changes in Medical Landscape	Pg. 16-20
V.	Section IV: Launch Timeline, Preparedness Metrics, and Resourcing	Pg. 21-26
VI.	Section V: Critical Success Factors and Major Pitfalls	Pg. 27-32
VII.	Section VI: Digital Influence on Launch Processes and Launch Tool Deployment	Pg. 33-41
VIII.	Section VII: Participant Demographics	Pg. 42-43
IX.	Section VIII: Detailed Benchmark Study Data	Pg. 44-55
X.	Section IX: About Best Practices, LLC	Pg. 56

List of Charts & Exhibits

I. Launch Excellence and Medical’s Role & Activity Effectiveness

Medical launch excellence framework
Medical Affairs’ role in oncology launches
Medical leadership roles in oncology launches
Medical Affairs’ effectiveness in oncology launch activities
Most effective launch activities for Medical Affairs in oncology
Improvement opportunities for Medical Affairs around oncology launch activities

II. Ensuring Cross-functional Alignment and Collaboration

Medical Affairs’ work with internal colleagues to ensure successful oncology launches
Role of Medical Affairs group in cross-functional oncology launch teams

III. Adopting to Ongoing Changes in Medical Landscape

Change fronts for Medical launch evolution
Medical Affairs’ launch evolution around digital data dissemination and communication
Medical Affairs’ launch evolution around medical education
Medical Affairs’ launch evolution around organizational support

IV. Launch Timeline, Preparedness Metrics and Resourcing

Medical Affairs’ oncology launch activities timeline
Total annual Medical Affairs launch investment in U.S. dollars and number of FTEs for oncology products during each of the years in launch phase
Launch dashboard and information used with the dashboard for oncology
Percentage of total Medical Affairs launch investment allocated to each of the listed Medical Affairs activities in oncology
Percentage of total Medical Affairs launch FTEs allocated to each of the listed Medical Affairs activities in oncology

V. Critical Success Factors and Major Pitfalls

Critical success factors for Medical Affairs in oncology launches
Areas where advanced team planning is key for oncology launches
Six critical areas for successful Medical Affairs launch readiness in oncology
Major pitfalls for Medical Affairs during oncology launches
Six major challenge areas for Medical Affairs during oncology launches

VI. Digital Influence on Launch Processes and Launch Tool Deployment

Post-pandemic digital technology utilization in Medical Affairs during oncology product launches
Impact of digital technologies on current and future oncology launch processes
Digital launch tool deployment and impact
Impact of top three digital activities that Medical leads in oncology
Impact of digital activities and programs used to support a successful oncology product launch
Top digital tools that can bring success to Medical Affairs product launch activities
Fast-growing digital tools that are impacting Medicals’ launch strategy
Example of a valuable digital tool that supports launch activities

VII. Participant Demographics

Geographic responsibility of benchmark partners

VIII. Detailed Benchmark Study Data

Role served by Medical Affairs in oncology product launches
Medical Affairs’ launch role effectiveness in oncology
Role served by Medical Affairs in planning, research, and education activities in oncology segment
Role served by Medical Affairs in data dissemination and organizational support activities in oncology segment
Role served by Medical Affairs in research activities in oncology segment
Role served by Medical Affairs in education and data dissemination support activities in oncology segment
Role served by Medical Affairs in organizational support activities in oncology segment
Medical Affairs launch activity involvement timeline - Evidence generation and field-based medical activities in oncology
Medical Affairs launch activity involvement timeline - Medical information and medical regulatory activities in oncology
Medical Affairs launch activity involvement timeline - HEOR activities and medical / scientific communications in oncology
Medical Affairs launch activity involvement timeline - Independent medical education and external engagement activities in oncology